15.97
-1.13 (-6.61%)
| Penutupan Terdahulu | 17.10 |
| Buka | 17.79 |
| Jumlah Dagangan | 468,171 |
| Purata Dagangan (3B) | 294,048 |
| Modal Pasaran | 577,203,712 |
| Harga / Jualan (P/S) | 2.76 |
| Harga / Buku (P/B) | 2.83 |
| Julat 52 Minggu |
| Margin Keuntungan | -61.82% |
| Margin Operasi (TTM) | -69.52% |
| EPS Cair (TTM) | -3.39 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 41.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 11.49% |
| Nisbah Semasa (MRQ) | 16.73 |
| Aliran Tunai Operasi (OCF TTM) | -35.04 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -26.02 M |
| Pulangan Atas Aset (ROA TTM) | -17.46% |
| Pulangan Atas Ekuiti (ROE TTM) | -35.75% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Menurun | Bercampur |
| Medical Devices (Global) | Menurun | Bercampur | |
| Stok | CeriBell, Inc. | Menurun | - |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 0.90 |
|
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| % Dimiliki oleh Orang Dalam | 9.97% |
| % Dimiliki oleh Institusi | 82.03% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Red Tree Management, Llc | 31 Dec 2024 | 2,205,661 |
| Yu Fan | 31 Dec 2024 | 1,222,202 |
| Abg-Wtt Global Life Science Capital Partners Gp Ltd | 31 Dec 2024 | 1,088,101 |
| Julat 52 Minggu | ||
| Median | 32.00 (100.38%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Ladenburg Thalmann | 04 Apr 2025 | 32.00 (100.38%) | Beli | 18.44 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| CHAO XINGJUAN | - | 17.59 | -25,000 | -439,750 |
| Jumlah Keseluruhan Kuantiti Bersih | -25,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -439,750 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 17.59 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| CHAO XINGJUAN | Pegawai | 15 May 2025 | Jual automatik (-) | 25,000 | 17.59 | 439,750 |
| CHAO XINGJUAN | Pegawai | 15 May 2025 | Pelaksanaan pilihan | 73,871 | - | - |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 20 May 2025 | Pengumuman | Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference |
| 08 May 2025 | Pengumuman | Ceribell Reports First Quarter 2025 Financial Results |
| 30 Apr 2025 | Pengumuman | Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems |
| 30 Apr 2025 | Pengumuman | Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference |
| 24 Apr 2025 | Pengumuman | Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025 |
| 15 Apr 2025 | Pengumuman | FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |